Atossa Therapeutics
ATOS
ATOS
86 hedge funds and large institutions have $28.3M invested in Atossa Therapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 86 → 86 (0)
32% less capital invested
Capital invested by funds: $41.6M → $28.3M (-$13.3M)
Holders
86
Holding in Top 10
–
Calls
$165K
Puts
$104K
Top Buyers
| 1 | +$995K | |
| 2 | +$251K | |
| 3 | +$234K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$200K |
| 5 |
VF
Virtu Financial
New York
|
+$149K |
Top Sellers
| 1 | -$46.7K | |
| 2 | -$43.4K | |
| 3 | -$36.4K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22K |
| 5 |
Squarepoint
New York
|
-$19.2K |